Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 148
Immune Disorders Drugs 79
Genomics 79
Biopharmaceuticals 79
Drug Discovery 66
Oncology Drugs 53
Biotechnology 49
Pharmaceuticals 43
Musculoskeletal Disorders Drugs 41
Hematological Drugs 38
Biosimilars and Biosuperiors 30
Cardiovascular Drugs 26
Clinical Trials 26
Alzheimer's Disease Drugs 26
Allergy and Immunology 20
Infusions and Injectables 20
Optical Disorders Drugs 19
Infectious Diseases Drugs 19
Respiratory Drugs 18
Mental Disorders Drugs 18
Gastrointestinal Drugs 17
Needles and Syringes 16
E-Healthcare 14
Psoriasis Drugs 14
Pharmaceutical Manufacturing 14
Immunosuppressive Drugs 14
Neurology 13
Healthcare Services 13
Hematology 13
Drug Delivery 12
Endocrine and Metabolic Disorders Drugs 12
Lymphoma Drugs 11
Analgesics 10
Leukemia Drugs 9
Optical 9
Diagnostics 9
Liver and Kidney Disorders Drugs 9
Therapeutic Area 8
Drugs by Therapeutic Area 7
Pulmonary Medicine 7
Medical Devices 7
Company Reports 6
Enzymes 6
Hospital Management 5
Cardiology 5
Oncology 5
Proteomics 4
Neurology Devices 4
Vaccines 4
Dermatological Drugs 4
Schizophrenia Drugs 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Pharmacoeconomics 3
Lung Cancer Drugs 3
Diabetes Devices 3
Stem Cells 3
Biomaterials 3
Mental Health 3
Vitamins and Dietary Supplements 3
Laboratory Equipment 3
Gastroenterology 3
In Vitro Diagnostics 2
Managed Care 2
Dermatology 2
Skin Cancer Drugs 2
Nanomedicine 2
Anxiety Drugs 2
Asthma Drugs 2
Urology and Nephrology 1
Women's Health 1
Fertility Services 1
Breast Cancer Drugs 1
Prostate Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Medical Imaging 1
Orthopedic Devices 1
Infectious Disease Testing 1
Computed Tomography 1
Transdermal and Transmucosal Drug Delivery 1
Biomarkers 1
Surgical Procedures 1
Contrast Media 1
Kidney Cancer Drugs 1
Antibiotics 1
Clinical Skills 1
Pediatrics 1
Anatomy 1
Allergy Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

913 Results (Page 8 of 46)
- Relevance
  Sort by

Disease Analysis: Alzheimer's Disease

 Report
June 2021
87 Pages
Global

€21856EUR$22,000USD£18,172GBP

Amyotrophic Lateral Sclerosis - Global Strategic Business Report

 Report
November 2024
183 Pages
Global

From

€4918EUR$4,950USD£4,089GBP

Spinal Muscular Atrophy - Global Strategic Business Report

 Report
November 2024
189 Pages
Global

From

€4918EUR$4,950USD£4,089GBP

Alzheimer's Therapeutics Market By Drug Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

 Report
September 2022
172 Pages
Global

From

€3547EUR$3,570USD£2,949GBP

Companion Diagnostic Collaboration and Licensing Deals 2010-2024

 Report
November 2024
300 Pages
Global

From

€3969EUR$3,995USD£3,300GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Schizophrenia Drugs Market 2021-2025

 Report
January 2022
120 Pages
Global

From

€2484EUR$2,500USD£2,065GBP

Fertility Drugs Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

Europe Recombinant Protein Manufacturing Services Market Size, Share & Trends Analysis Report By Service Type (Pre-clinical & Clinical), By Host Cell (Mammalian, Bacterial), By End-use, By Country, And Segment Forecasts, 2023 - 2030

 Report
August 2023
98 Pages
Europe

From

€5911EUR$5,950USD£4,915GBP

Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Providers, By Regional Outlook and Forecast, 2021-2027

 Report
February 2022
159 Pages
Global

From

€3576EUR$3,600USD£2,974GBP

Idiopathic Pulmonary Fibrosis Market by Drug Type, Distribution Channel, End-User - Global Forecast 2025-2030

 Report
October 2024
195 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

 Report
April 2020
536 Pages
Global

From

€4867EUR$4,899USD£4,047GBP

Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

 Report
July 2024
120 Pages
Global

From

€5911EUR$5,950USD£4,915GBP

Intestinal Pseudo Obstruction Treatment Global Market Report 2024

 Report
March 2024
175 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

Ophthalmology Drugs & Devices Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€4123EUR$4,150USD£3,428GBP

Biomarker Clinical Phase Outsourcing Services Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€4123EUR$4,150USD£3,428GBP

Anxiety Disorders and Depression Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4719EUR$4,750USD£3,924GBP

Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

Psoriasis Drugs Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

 Report
October 2023
173 Pages
Global

From

€4471EUR$4,500USD£3,717GBP

Biosimilar Monoclonal Antibody Market By Type, By Indication, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032

 Report
August 2023
293 Pages
Global

From

€3547EUR$3,570USD£2,949GBP

Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
696 Pages
Global

From

€2484EUR$2,500USD£2,065GBP

913 Results (Page 8 of 46)
- 1
- 6
- 7
- 8
- 9
- 10

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.